does tirzepatide cause rapid heart rate is a next-generation dual agonist that targets both GLP-1 and GIP receptors to help regulate appetite, support metabolic balance, and drive meaningful weight loss. To match your unique physiology and treatment What are the side effects

placebo INDIANAPOLIS, May 21, 2026 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY), the maker of Zepbound (tirzepatide) and Foundayo (orforglipron), today announced positive topline results from TRIUMPH-1, a Phase 3 clinical trial evaluating the efficacy and safety of retatrutide, an investigational, first-in-class GIP, GLP-1, and glucagon triple hormone receptor agonist, in adults with obesity or overweight and at least one weight-related comorbidity and without diabetes

The result in research models is a smaller GH signal than the combination produces, because the amplified sensitivity has nothing acting strongly upon it

Welcome to the era of what social media has nicknamed "Ozempic tongue." What Exactly Is Ozempic Tongue

Understanding these side effects is vital for weight loss seekers to make informed decisions about their treatment options

[1] [8] These drugs mimic the action of naturally occurring GLP-1, an incretin hormone produced in the intestine following food intake